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A boy with congenital analbuminemia and steroid-sensitive
idiopathic nephrotic syndrome: an experiment of nature
Abstract
In this paper, a boy is reported with the association of congenital analbuminemia (CAA) and
steroid-sensitive idiopathic nephrotic syndrome (INS), two conditions resulting independently in
reduced colloid oncotic pressure. The unique occurrence helps confirm earlier reports that albumin is
not the exclusive factor responsible for maintaining colloid oncotic pressure.
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Abstract 
A boy is reported with the association of congenital analbuminemia and steroid-sensitive 
idiopathic nephrotic syndrome, two conditions resulting independently in reduced colloid 
oncotic pressure. The unique occurrence helps confirm earlier reports that albumin is not the 
exclusive factor responsible for maintaining colloid oncotic pressure. 
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Introduction 
Congenital analbuminemia (CAA) is a rare autosomal recessive disorder [9] in which subjects 
have little or no circulating serum albumin due to defective albumin synthesis in the liver 
[23]. Fewer than 50 patients have been recorded so far in the continuously updated Register of 
Analbuminemia Cases [18]. Idiopathic nephrotic syndrome (INS) has a prevalence of 1 in 
6,000 children and is characterized by hypoproteinemia, proteinuria and edema. 
Approximately 90% of children with INS respond to steroids, and renal histology mainly 
shows minimal change nephropathy [19]. The underlying pathogenetic mechanism of INS is a 
defective glomerular permselectivity resulting in albuminuria and hypoalbuminemia (<2.5 
g/dl) leading to loss of serum oncotic pressure. We report a boy with the incidental 
association of CAA and steroid-sensitive INS. 
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Case report 
The male patient was born at term (37 week gestation), but “small-for-gestational-age” with 
weight (2.2 kg) and length (44 cm) <3rd percentile. Pregnancy had been complicated by 
polyhydramnios. Mild peripheral edema was noted at three days of age. Further investigations 
revealed moderate hypoproteinemia (3.5 g/dl) and marked hypoalbuminemia (1.4 g/dl). At the 
age of nine months, the diagnosis of CAA was confirmed with serum albumin persistently 
below 0.2 g/dl; urinalysis and faecal concentration of alpha1-antitrypsin were normal, making 
urinary or enteral loss unlikely. At the age of four years, serum proteins (agarose gel 
electrophoresis) and lipids were as follows (table 1): Albumin was very low. Alpha 1 
globulins (main constituents: 1-lipoprotein, 1-glycoprotein, 1-antitrypsin), alpha 2 
globulins (2-macroglobulin, pre--lipoprotein, haptoglobin) and beta globulins (transferrin, 
-lipoprotein, complement) were elevated. Gamma globulins, IgG, IgA, IgM were normal. 
Total and LDL cholesterol (enzymatic analysis) were markedly elevated, HDL cholesterol 
was just above reference range. Lipoprotein(a) and triglycerides (turbidimetric analysis) were 
elevated. There was no proteinuria. The further clinical course was uneventful apart from 
recurrent mild upper respiratory tract infections associated twice with a febrile convulsion; an 
electroencephalogram was normal. 
 When DNA sequence analysis of the human albumin gene became available, a C → T 
substitution at nucleotide 4446 was identified in the proband [4].  The mutation changes the 
codon CGA for Arg 114 to a stop codon TGA, resulting in premature termination and 
responsible for the analbuminemic trait. The putative protein product, called Albumin Zurich, 
would have a length of 113 residues.  
 At the age of 5 years, he was admitted to our hospital because the parents had noticed 
swelling of the legs and weight gain of two kilograms during the previous month. Clinical 
examination showed blood pressure in the upper normal range (110/70 mm Hg) and – apart 
from swelling of the legs and the face – no further abnormalities, in particular no evidence of 
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hypovolemia. Height and weight were 111 cm (50th percentile) and 23 kg (90th – 97th 
percentile), respectively. On the assumption, that the clinical condition was caused by the 
CAA, the patient was given immediately after admission (defined as day 0) a single dose of 
albumin intravenously (i.e., 100 ml of albumin 20%; purity of albumin ≥96%). Urine had 
been routinely collected before albumin was given, but the result was noticed only after the 
albumin infusion had been administered and unexpectedly revealed proteinuria (2+ on 
Combur Stix, Roche, Basle, Switzerland). Combur Stix is highly sensitive, but not specific 
for albumin, detecting also other proteins. There was no hematuria. Further serum and urinary 
laboratory investigations were performed on day 1, i.e., after the albumin infusion (table 1). 
Renal function, assessed as plasma creatinine (0.4 mg/dl; Jaffé method), and sodium were 
normal. 
 Serum albumin rose on day 1, i.e., 8 hours after the albumin infusion, to a maximum 
concentration of 11.6 g/l and returned to baseline on day 10 with an estimated serum half-life 
(T½) of <5 days. Serum alpha 2 globulins and cholesterol showed a transient increase from 
baseline; in contrast, alpha 1 globulins, beta globulins and gamma globulins and IgG were 
transiently decreased. 24-hour proteinuria on day 1 consisted mainly of albumin. On day 10, 
proteinuria persisted, but albuminuria was almost absent and the main urinary protein 
constituents (agarose gel electrophoresis) were alpha 1 and beta globulins. Qualitative sodium 
dodecyl sulphate polyacrylamide gel (SDS-page) urinary electrophoresis on day 1 and day 10 
revealed also transferrin, IgG, IgM and complement C3. 
 The presumptive diagnosis was idiopathic nephrotic syndrome (INS). However, as 
hypoalbuminemia as diagnostic hallmark of INS was difficult to interpret in the context of 
CAA, a renal biopsy was performed on day 5. Light microscopy showed 14 normally 
structured glomeruli and immunofluorescence was negative; electron microscopy revealed 
effacement of foot processes involving about 80% of the glomerular capillary circumferences, 
leading to the diagnosis of minimal change nephropathy (Figure 1). On day 6, oral prednisone 
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(40 mg per day) was started. On day 21, the patient came into remission (i.e., no proteinuria). 
On day 37, a detailed analysis of serum and urine was repeated (Table 1). Prednisone was 
continued for six weeks, than switched to 25 mg on alternate days for further six weeks. No 
relapse of the INS has occurred so far. 
 Currently, at the age of eleven years, the boy is healthy apart from occasional mild 
infections of the upper airways. Blood pressure (95/60 mm Hg), height (144.5 cm, 25th – 50th 
centile) and weight (40.8 kg; 75th centile) is normal, and there is no peripheral edema. The 
serum protein and lipid pattern is identical with the results obtained at 4 years of age; 
urinalysis shows no proteinuria (table 1). X-ray of hands and knees reveal normal osseous 
structure. The non-consanguineous Swiss parents, heterozygous for the C → T substitution at 
nucleotide 4446 [4], are healthy and have a slightly decreased serum albumin concentration 
(father: 3.2 g/dl; mother: 3.6 g/dl). Family history is negative for miscarriages or neonatal 
deaths. 
 
Discussion 
This report describes a boy with CAA and steroid-sensitive INS, a unique association of two 
conditions resulting independently in reduced colloid oncotic blood pressure. CAA is a rare 
autosomal recessive disorder [4,9,18,21] leading to defective albumin synthesis in the liver 
[23] with subsequent very low serum albumin concentration (<0.2 g/dl). If albumin is 
administered intravenously to patients with CAA, its biologic half-life is prolonged to 38 – 50 
days (reference range: 16 – 20 days) [21,23]; on the contrary, the half-life in our patients was 
very short (<5 days), raising the question of albuminuria.  
 Colloid oncotic blood pressure in healthy individuals is mainly maintained by serum 
albumin (normal range: 26 – 31 mm Hg) [12,20]. The oncotic pressure in patients with CAA 
is persistently decreased to about half of its normal value [12,16]. Marked edema, however, is 
absent, and only half of these patients present with mild peripheral edema, indicating the 
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presence of edema-preventive measures [reviewed in 12,16]. Increased concentrations of non-
albumin proteins (mainly alpha 1, alpha 2 and beta globulins) [8,12,23] and lipoproteins 
[8,12,16,21], and lowering in parallel of the interstitial oncotic pressure through washout of 
interstitial colloids and increased lymph drainage, mitigate the effect on the capillary oncotic 
pressure and the transcapillary oncotic gradient [8,12,16]. In addition, there is a reduction of 
the hydrostatic pressure gradient by lowering the capillary blood pressure and increasing the 
interstitial pressure [14]. Experimental data on the effect of hypoalbuminemia on the capillary 
permeability are controversial: Wraight et al showed a decreased glomerular permeability to 
proteins in rats made acutely hypoalbuminemic after plasmapheresis [24] whereas Fujihara et 
al demonstrated enhanced glomerular permeability to macromolecules in the (chronic) 
analbuminemic Nagase rat [6]. When our patient was in remission, he had no proteinuria 
suggesting that permeability for macromolecules was not enhanced. 
 Children with INS present with marked edema, typically resulting in weight gain. 
Proteinuria mainly consists of albumin, but other proteins including transferrin [3] and gamma 
globulins (IgG, subclasses) [1,17] are also lost in the urine though to a much lesser amount. 
Albuminuria and hypoalbuminemia result in acute reduction of colloid oncotic pressure with 
low values (≤12 mm Hg) [20] comparable to patients with CAA. This leads – at least in a 
subgroup of children with steroid-sensitive INS – to hypovolemia and secondary activation of 
the renin-angiotensin-aldosterone axis, the sympathetic nervous system and vasopressin 
secretion with subsequent edema formation, consistent with the “underfilling” hypothesis 
[summarised in 20]. However, most studies from (mainly adult) patients with the nephrotic 
syndrome have failed to find a consistent reduction in blood and plasma volume, suggesting 
primary renal sodium retention [14,20]. In addition to renal molecular mechanisms, increased 
hydraulic conductivity due to transconformation of endothelial intercellular junctions driving 
the leakage of fluid into the interstitium has been suggested [5]. Immune mechanisms related 
to release of cytokines in INS, leading to generalized vascular hyperpermeability have also 
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been postulated [15]: The role of circulating vascular endothelial growth factor (VEGF) is, 
however, controversial [2,22]. 
 The defense mechanisms in nephrotic syndrome against edema formation are – at least 
partially – similar to CAA, i.e., lowering in parallel of the interstitial oncotic pressure through 
washout of interstitial colloids and increased lymph drainage, and reduction of the hydrostatic 
pressure gradient by lowering the capillary blood pressure and increasing the interstitial 
pressure [14,20]. Additional defense mechanisms in children with INS and concomitant 
hypovolemia and hyponatremia (both not present in our patient), include unidentified 
endogenous osmoles [10,13]. The colloid oncotic pressure in patients with CAA and INS is 
comparable. Whereas the low oncotic pressure state is a chronic condition in CAA, allowing 
for effective edema-preventive measures, the pressure changes occur very fast in INS and thus 
preclude successful defensive mechanisms. 
 The question, however, arises why this patient with INS and CAA did develop edema 
at all as the CAA makes the usual cause for edema irrelevant. In fact, the clinical presentation 
of the INS, i.e., the extent of edema, in this patient was mild. We hypothesize that at least two 
mechanisms might have contributed. 
 Firstly, some of the serum proteins in patients with CAA compensating for the low 
albumin have a higher MW than albumin (MW 66 kD) [7], in particular the main constituents 
of alpha 2 globulins (2-macroglobulin: MW 725 kD; pre--lipoprotein: MW >3000 kD; 
haptoglobin: MW 100 kD) [7], precluding major glomerular filtration. In fact, serum alpha 2 
globulins were elevated during the INS, thereby “defending” oncotic pressure. In contrast to 
alpha 2 globulins, two other non-albumin constituents maintaining oncotic pressure in CAA – 
i.e., alpha 1 and beta globulins – have MW comparable to albumin (1-glycoprotein: MW 55 
kD, 1-antitrypsin: MW 50 kD; transferrin: MW 77 kD) [7]: They were the main urinary 
protein constituents during the INS and their serum concentrations were decreased, leading to 
reduced oncotic pressure. Typically for minimal-change nephropathy – and often in contrast 
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to focal segmental glomerulosclerosis – only a small amount of gamma globulins (<<1g/d) 
was lost in the urine [1]. The main cause of hypogammaglobulinemia during a relapse of INS 
is not urinary loss, but a primary immunological mechanism, and low serum IgG persists for 
months after remission [11]. 
 Secondly, the additional reduction of the colloid oncotic pressure, superimposed on an 
already low baseline oncotic pressure, might have exerted only a minor effect. As expected in 
INS, serum cholesterol showed a transient increase beyond the highly elevated baseline 
concentration.  
 A few publications have reviewed the clinical presentation and long-term outcome of 
patients with CAA [8,9,12,16,21]. However, follow-up data are incomplete and inconsistent 
in some cases. Thus, despite the very high serum concentrations of total and LDL cholesterol, 
the risk of progressive atherosclerosis and cardiovascular events is still not well defined; yet, 
an increased risk of atherosclerosis cannot be excluded [8,9,12,16,21]. Well documented 
complications were lipodystrophy (mainly in adult females) and osteoporosis. Neonatal 
presentation occasionally included low birth weight (“small-for-gestational-age”) and mild 
peripheral edema. Apart from recurrent mild respiratory infections, no additional clinical 
findings were observed in children. In contrast to the benign outcome after birth, the prenatal 
course of affected fetuses appears less favorable as maternal miscarriages and neonatal deaths 
were reported in family histories [12,21]. 
 We conclude that this experiment of nature – the unique association of congenital 
analbuminemia and idiopathic nephrotic syndrome – helps confirm that serum albumin is not 
the exclusive factor responsible for maintaining oncotic pressure. The precise information on 
the transient changes of various proteins in blood and urine might contribute to a better 
understanding of both conditions. 
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Figure 1. Renal biopsy 
 
 
Fehler! Es ist nicht möglich, durch die Bearbeitung von Feldfunktionen Objekte zu 
erstellen. 
 
Legend:   Electron micrograph of a portion of a glomerulus with effacement of foot   
processes (arrows) and vacuolization of podocytes (asterisks).  
(Uranyl acetate and lead citrate; x 7500) 
 
Table 1. Biochemical parameters in serum und and urine 
 
 
* Day  1 = after administration of albumin 20 g i.v. on day 0; ** Day 37: in remission; *** all results outside reference range in bold 
 
Date 
 
Normal range 
( age 4 years) 
Age 4 years Age 5 years: INS 
       Day 1*                      Day 10                      Day 37** 
Age 11 years 
2007 
Serum       
Total protein: g/l 60 – 80 46*** 40 41 54 50 
Albumin: g/l 37 – 45 2.6 11.6* 2.4 2.6 1.1 
Alpha 1 globulins: g/l 1.2 – 2.8 4.5 1.8 3.2 5.9 4.7 
Alpha 2 globulins: g/l 4.3 – 8.3 13.9 15.0 19.1 19.0 16.6 
Beta globulins: g/l 4.9 – 8.1  15.4 9.5 12.9 20.3 18 
Gamma globulins: g/l 4.9 – 10.5  9.6 2.1 3.4 6.3 9.7 
Total IgG: g/l 6 – 12 8.0 1.5 1.9 5.1 8.9 
   IgG1 4 – 11   1.1  5.7 
   IgG2 0.85 – 4.1   1.1  2.7 
   IgG3 0.13 – 1.42   0.3  0.7 
   IgG4 0.03 – 1.89   0.2  0.6 
IgA: g/l 0.5 – 2 1.9  1.6 2.2 2.4 
IgM: g/l 0.5 – 1.5 1.1  0.9 1.5 1.0 
Sodium: mmol/l 135 – 145 137 137 139 137 139 
Cholesterol: mmol/l 1.6 – 4.9 12.3 18.9 17.2 20.4 13.8 
   HDL-cholesterol 1.0 – 1.3  1.6    1.1 
   LDL-cholesterol 2.9 – 4.9 9.7    11 
Apo-lipoprotein A1: g/l 1.1 – 1.8     1.3 
Apo-lipoprotein B: g/l 0.6 – 1.4     2.8 
Lipoprotein (a): g/l < 0.56 2.0    4.4 
Triglycerides: mmol/l 0.5 – 1.6 2.2 4.0 3.7  3.6 
Urinary excretion: g/24-hours       
Protein  0 4.2 3.1 0 0 
Albumin  0 3.0 0.1 0 0 
Alpha 1 globulins  0 0.7 1.4 0 0 
Alpha 2 globulins  0 0.1 0.5 0 0 
Beta globulins  0 0.3 0.8 0 0 
Gamma globulins 
 0 0.1 0.3 0 0 
